港股详情

本页面由TTMF Limited提供服务

华芢生物-B待上市

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：- -

开：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：1.18亿

香港流通股本：8,302.21万

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

市销率: - -

1

开始申购

12/12

2

申购截止

12/17 09:30

3

公布中签

12/18

4

暗盘

12/19 16:15 - 18:30

5

挂牌上市

12/22

总览公司新闻资讯公告

价格范围

38.20 ~ 51.00 HKD

发行价

- -

发行量

1,764.88万

预计市值

44.95亿 ~ 60.01亿 HKD

最低申购数量

200

承销商

华泰金融控股(香港)有限公司

查看招股说明书

新闻资讯

IPO周报｜本周5只新股申购，全球超导磁体龙头企业来了

华芢生物上市进程稳步推进稀缺PDGF管线填补糖足治疗空白

BRIEF-中国南华期货等4支新股启动香港IPO合计筹最多35亿港元，12月22日挂牌上市

【新股IPO】华芢生物-B(02396)今日起招股入场费10302.88港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02396"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02396","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","market":"HK","secType":"STK","nameCN":"华芢生物-B","latestPrice":0,"timestamp":1765778556732,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":83022145,"shares":117657522,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"12-15 14:02:36","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":8,"adr":0,"listingDate":1766332800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":0,"ipoDetail":{"name":"华芢生物－Ｂ","exchange":"SEHK","listingDate":"2025-12-22","sharesOutstanding":117657522,"sharesFloat":117657522,"offerAmount":17648800,"priceRange":"38.200 - 51.000","market":"HK","openProspectusDate":"2025-12-12","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1212/2025121200082_c.pdf","purchaseBeginDate":"2025-12-12","purchaseEndDate":"2025-12-17","winningDate":"2025-12-19","currency":"HKD","minPurchaseQuantity":200,"peRate":-23.18,"use":"1、约61.8%或437.6百万港元，将用于资助公司核心产品Pro101-1及Pro-101-2的持续临床开发及商业化；\n2、约18.8%或133.5百万港元，将用于通过购买与研发及质量控制活动相关的专业设备及仪器来提升公司研发能力；\n3、约6.3%或44.5百万港元，将用于支付公司核心产品以外的PDGF产品用于治疗其他适应症的持续临床前研发的第三方服务费、研发人员费用及原材料成本；\n4、约3.1%或22.3百万港元，将用于支付Mes-201、Oli-101及Oli201临床前研发活动的第三方服务费、研发人员费用及原材料成本；\n5、约10.0%或70.9百万港元，用作营运资金及一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司是一家总部位于中国的生物制药公司，致力于开发疗法，重点是针对有医疗需求及市场机会的适应症开发蛋白质药物，主攻方向是发现、开发和商业化伤口愈合的疗法，目前为PDGF药物。","subscribed":110.98,"marketCap":4495000000,"minimumCapital":10302.88,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,700000,882400"},"greyMarketDetail":{"greyDate":"2025-12-19","greyDateTimestamp":1766073600000,"greyOpeningTime":1766132100000,"greyClosingTime":1766140200000,"showGreyQuote":false,"openProspectusDate":"2025-12-12","listingDate":"2025-12-22"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","floatShares":83022145,"roa":"--","roe":"--","lyrEps":0,"shares":117657522,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/02396\",,undefined,":{"id":9245,"type":"COMMON","ipoName":"02396-IPO","symbol":"02396","companyName":"华芢生物-B","market":"HK","currency":"HKD","status":"OPEN","underwriter":"华泰金融控股(香港)有限公司","lotSize":200,"minQty":200,"expectedOfferingSize":17648800,"openingDate":1765503000000,"closingDate":1765935000000,"commonClosingDate":1765935000000,"allotmentDate":1765987200000,"listDate":1766332800000,"marginable":true,"marginRate":10,"latestPrice":51,"minPrice":38.2,"maxPrice":51,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1212/2025121200082_c.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,700000,882400],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1765900800000,"interestEndDate":1765900800000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1766132100000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"02396-IPO","financingId":55872,"type":1,"availableFundLimit":10302.86,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":103028.6,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1765503000000,"closeTime":1765935000000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":10302.86,"threshold":8000000000,"isAvailable":false},{"ipoName":"02396-IPO","financingId":55865,"type":4,"availableFundLimit":10302.86,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1765503000000,"closeTime":1765935000000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":10302.86,"threshold":10000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"CASH","closeTime":1765935000000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":10302.86},{"method":"FINANCING","closeTime":1765935000000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":10302.86}],"latestClosingDate":1765935000000,"subscribedFinanceRatio":108.09,"subscribedRatio":108.09,"forecastRatio":125.39,"raiseMoney":90020000,"totalMargin":9730170000,"quoteInfoUpdatedAt":1765778147384,"forecastMarketValue":5247525481.2,"minForecastMarketValue":4494517340.400001,"maxForecastMarketValue":6000533622,"sharesOutstanding":117657522,"business":"公司是一家总部位于中国的生物制药公司，致力于开发疗法，重点是针对有医疗需求及市场机会的适应症开发蛋白质药物，主攻方向是发现、开发和商业化伤口愈合的疗法，目前为PDGF药物。","greyOpeningTime":1766132100000,"greyClosingTime":1766140200000,"tradable":true},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02396\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591366098","title":"IPO周报｜本周5只新股申购，全球超导磁体龙头企业来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2591366098","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591366098?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 07:36","pubTimestamp":1765755360,"startTime":"0","endTime":"0","summary":"本周A股市场将迎来5只新股申购。澎湃新闻根据Wind及公开信息梳理统计，本周有5只新股安排申购，分别为宁波健信超导科技股份有限公司、苏州江天包装科技股份有限公司、上海誉帆环境科技股份有限公司、强一半导体（苏州）股份有限公司、内蒙古双欣环保材料股份有限公司。其中，周一申购的健信超导是全球最大的医用MRI超导磁体第三方独立供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-12-15/doc-inhavser4346221.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-15/doc-inhavser4346221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02546","SOXX","BK4585","03881","02695","001396","001369","BK4142","VAC","02396","688809","LU0053671581.USD","SMH","BK4588","688805","02581","02691"],"gpt_icon":1},{"id":"2590573465","title":"华芢生物上市进程稳步推进 稀缺PDGF管线填补糖足治疗空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2590573465","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590573465?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 15:06","pubTimestamp":1765523182,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）12月12日，专注于伤口愈合多功能疗法的创新药企华芢生物科技（青岛）股份有限公司（以下简称“华芢生物”）上市进程正顺利推进，公司相关上市筹备工作已进入关键阶段，其稀缺的PDGF药物管线及广阔的市场前景引发行业广泛关注。据悉，华芢生物成立于2012年，已布局十款候选产品、覆盖14种创面愈合适应症，核心产品矩阵具备显著竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512123590099089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02396"],"gpt_icon":0},{"id":"2590528026","title":"BRIEF-中国南华期货等4支新股启动香港IPO合计筹最多35亿港元，12月22日挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2590528026","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590528026?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 09:06","pubTimestamp":1765501614,"startTime":"0","endTime":"0","summary":"BRIEF-中国南华期货等4支新股启动香港IPO合计筹最多35亿港元，12月22日挂牌上市路透香港12月12日 - 据联交所公告：* 中国期货公司南华期货股份603093.SS拟发售约1.08亿股H股，招股价区间为每股12-16港元，集资12.9-17.2亿港元，新股编号“2691.HK”* 专注伤口愈合疗法的中国生物制药公司--华生物拟发售约1,765万股股份，招股价区间为每股38.2-51港元","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4T3XI02J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1213","603093","02396","00413","02691","BK0276"],"gpt_icon":0},{"id":"2590284225","title":"【新股IPO】华芢生物-B(02396)今日起招股 入场费10302.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590284225","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590284225?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 08:48","pubTimestamp":1765500493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华生物-B 今日起招股，拟发行1764.88万股H股，其中10%为香港发售，90%为国际发售，另有15%超额配股权。每股招股价介于38.2港元至51港元，每手200股，入场费10302.88港元。股份预期将于2025年12月22日挂牌上市，华泰国际、中信证券为联席保荐人。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NGRkYjNjMjA4MTA4NTEzNjUxMTI4.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NGRkYjNjMjA4MTA4NTEzNjUxMTI4.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971413","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}